End-of-day quote
Shenzhen S.E.
06:00:00 2024-06-06 pm EDT
|
5-day change
|
1st Jan Change
|
13.55
CNY
|
+6.53%
|
|
+8.05%
|
+29.54%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,873
|
19,134
|
13,208
|
11,065
|
14,334
|
-
|
-
|
Enterprise Value (EV)
1 |
2,873
|
19,134
|
13,208
|
11,065
|
14,334
|
14,334
|
14,334
|
P/E ratio
|
24.8
x
|
12.2
x
|
6.1
x
|
22.3
x
|
14
x
|
11.7
x
|
8.21
x
|
Yield
|
-
|
-
|
-
|
-
|
1.92%
|
2.29%
|
2.51%
|
Capitalization / Revenue
|
-
|
-
|
0.64
x
|
0.65
x
|
0.81
x
|
0.77
x
|
0.73
x
|
EV / Revenue
|
-
|
-
|
0.64
x
|
0.65
x
|
0.81
x
|
0.77
x
|
0.73
x
|
EV / EBITDA
|
-
|
-
|
3.62
x
|
5.08
x
|
5.96
x
|
5.4
x
|
3.7
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-13.1
x
|
14.2
x
|
10.5
x
|
FCF Yield
|
-
|
-
|
-
|
-
|
-7.65%
|
7.04%
|
9.53%
|
Price to Book
|
-
|
-
|
2.82
x
|
1.68
x
|
1.97
x
|
1.75
x
|
1.47
x
|
Nbr of stocks (in thousands)
|
897,867
|
897,867
|
897,867
|
1,057,867
|
1,057,867
|
-
|
-
|
Reference price
2 |
3.200
|
21.31
|
14.71
|
10.46
|
13.55
|
13.55
|
13.55
|
Announcement Date
|
4/29/21
|
4/8/22
|
3/12/23
|
4/12/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
-
|
20,713
|
17,042
|
17,703
|
18,602
|
19,694
|
EBITDA
1 |
-
|
-
|
3,646
|
2,179
|
2,404
|
2,654
|
3,875
|
EBIT
1 |
-
|
-
|
2,952
|
1,059
|
1,609
|
1,864
|
2,694
|
Operating Margin
|
-
|
-
|
14.25%
|
6.22%
|
9.09%
|
10.02%
|
13.68%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
2,969
|
968.8
|
1,594
|
1,851
|
2,666
|
Net income
1 |
115.8
|
1,569
|
2,164
|
453.1
|
1,024
|
1,220
|
1,745
|
Net margin
|
-
|
-
|
10.45%
|
2.66%
|
5.78%
|
6.56%
|
8.86%
|
EPS
2 |
0.1290
|
1.748
|
2.411
|
0.4698
|
0.9700
|
1.153
|
1.650
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
-1,097
|
1,009
|
1,367
|
FCF margin
|
-
|
-
|
-
|
-
|
-6.2%
|
5.43%
|
6.94%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
38.02%
|
35.27%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
82.74%
|
78.32%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
0.2600
|
0.3100
|
0.3400
|
Announcement Date
|
4/29/21
|
4/8/22
|
3/12/23
|
4/12/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
-1,097
|
1,009
|
1,367
|
ROE (net income / shareholders' equity)
|
-
|
-
|
60.8%
|
8.24%
|
14%
|
14.8%
|
17.6%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
10.7%
|
-
|
5%
|
5.55%
|
7.9%
|
Assets
1 |
-
|
-
|
20,266
|
-
|
20,480
|
21,976
|
22,089
|
Book Value Per Share
2 |
-
|
-
|
5.210
|
6.210
|
6.890
|
7.740
|
9.190
|
Cash Flow per Share
2 |
-
|
-
|
4.300
|
1.540
|
1.770
|
1.680
|
-
|
Capex
1 |
-
|
-
|
2,203
|
1,492
|
1,374
|
1,341
|
1,447
|
Capex / Sales
|
-
|
-
|
10.64%
|
8.75%
|
7.76%
|
7.21%
|
7.34%
|
Announcement Date
|
4/29/21
|
4/8/22
|
3/12/23
|
4/12/24
|
-
|
-
|
-
|
Last Close Price
13.55
CNY Average target price
13.84
CNY Spread / Average Target +2.14% Consensus |
1st Jan change
|
Capi.
|
---|
| +29.54% | 1.98B | | +3.28% | 77.85B | | -4.06% | 45.15B | | +4.00% | 33.45B | | +15.05% | 19.03B | | +15.01% | 12.15B | | -1.50% | 10.56B | | -21.68% | 10.17B | | -1.30% | 9.08B | | -6.85% | 8.2B |
Diversified Chemicals
|